Relationsip between PTEN and VEGF expression and clinicopathological characteristics in HCC

Abstract

To investigate the expressions and significance of the tumor suppressor gene phosphatase and tensin homlog deleted on chromosome ten protein (PTEN) and vascular endothelial growth factor (VEGF) in hepatocellular carcinoma (HCC), and to analyze the relationship between their expressions and the tumor’s invasion and their pericarcinomatous tissues, the correlation of their expressions with the tumor’s clinicopathological characteristics and invasion potential were studied. Our study showed that the expression level of PTEN in HCC was remarkably lower than that in pericarcinomatous liver tissues, while the expressions of both VEGF and MVD were higher than that in pericarcinomatous liver tissues. Correlation analysis revealed that the expression of PTEN was negatively related to the progression of the pathological differentiation and invasion of tumor, whereas the expressions of VEGF and MVD were positively related. Moreover, there was a negative relationship between the expression of PTEN and the expressions of VEGF and MVD, and a positive one between VEGF and MVD. The expressions of PTEN and VEGF may reveal the degree of differentiation and the invasive potential of HCC tissues. The mechanism by which the lack of PTEN expression probably induces abnormal hyperexpression of VEGF may play an important role in the invasion and metastasis of HCC.

Keywords

hepatocyte carcinoma / phosphatase and tensin homlog deleted on chromosome ten protein / vascular endothelial growth factor / microvessel density

References

[1] LiJ., YenC., LiawD., et al.. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275(5308): 1943-1947

[2] SengerD. R., GalliS. J., DvorakA. M., et al.. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 1983, 219: 983-985

[3] The cancer of the liver italian program. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology, 1998, 28(3): 751-755

[4] el-AssalO. N., YamanoiA., SodaY., et al.. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery, 1997, 122(3): 571-577

[5] WeinderN., SempleJ. P., WelchW. R., et al.. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med, 1991, 324(1): 1-8

[6] ChaoY., LiC.P., ChauG. Y., et al.. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol, 2003, 10(4): 355-362

[7] MiuraH., MiyazakiT., KurodaM., et al.. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J Hepatology, 1997, 27(5): 854-861

[8] TamuraM., GuJ., MatsumotoK., et al.. Inhibition of cell migration, spreading,and focal adhesions by tumor suppressor PTEN. Science, 1998, 280(5369): 1614-1617

[9] KoulD., ShenR., GaryaliA., et al.. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol, 2002, 21(3): 469-475

[10] FolkmanJ.. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer, 1996, 32A(14): 2534-2539

[11] FolkmanJ., ShingY.. Angiogenesis. J Biol Chem, 1992, 267(16): 10931-10934

[12] ZolotaV., GerokosataA., MelachrinouM., et al.. Microvessel density, proliferating activity, p53 and bc122 expression in situ ductal carcinoma of the breast. Anticancer Res, 1999, 19: 3269-3274

[13] HisaiH., KatoJ., KobuneM., et al.. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res, 2003, 9(13): 4852-4859